Morgan Stanley Maintains Overweight on Vistra, Lowers Price Target to $226

Benzinga · 2d ago
Morgan Stanley analyst Stephen Byrd maintains Vistra (NYSE:VST) with a Overweight and lowers the price target from $227 to $226.